https://european-biotechnology.net/wp-content/uploads/2026/04/generare-ai-team-paris-web.png541960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-04-02 06:01:332026-04-02 06:01:33French AI: 20 million funding for Generare to find better data in nature
https://european-biotechnology.net/wp-content/uploads/2026/04/getty-images-7G9O2iyJZ_k-unsplash-1030x688-1.jpg6881030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-04-01 08:00:392026-04-01 08:00:39Lilly moves deeper into sleep medicine with up to $7.8 billion Centessa deal
https://european-biotechnology.net/wp-content/uploads/2026/03/Novatis.jpg450940Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-30 07:58:252026-03-30 07:58:25Something of a shopping spree: Novartis to acquire US-based Excellergy for up to $2bn
https://european-biotechnology.net/wp-content/uploads/2026/03/kelli-mcclintock-W3uA3xTRfeA-unsplash-scaled-e1774626079838-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-30 05:00:542026-03-30 05:00:5410 European Startups to watch in 2026
https://european-biotechnology.net/wp-content/uploads/2026/03/a-chosen-soul-DIFqU-oBCg4-unsplash-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-26 16:12:082026-03-26 16:12:08TenBoron lands €7.6m EU grant for precision radiotherapy trials in hard-to-treat cancers
https://european-biotechnology.net/wp-content/uploads/2026/03/point-normal-V_VLNr6qtn4-unsplash-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-25 12:09:542026-03-25 12:09:54Immutrin secures £65m Series A for amyloid-removing heart therapy
